Skip to main content

Custom Accounting Solutions

View Categories

About the R&D program

3 min read

Aims of the R&D program #

The research and development (R&D) tax incentive aims to boost competitiveness and improve productivity across the Australian economy by:

  • encouraging industry to conduct R&D that may not otherwise have been conducted
  • improving the incentive for smaller firms to undertake R&D
  • providing business with more predictable, less complex support.

Changes since 1 July 2021 #

The following changes were announced in 2020 to the R&D tax incentive that apply for income years commencing on or after 1 July 2021:

  • The refundable offset rate of 43.5% has been replaced with an offset rate of 18.5% above the company’s tax rate.
  • The flat non-refundable rate of 38.5% has been replaced with a progressive marginal tiered R&D intensity threshold. Increasing rates of benefit apply for incremental research and development expenditure by intensity:
    • 0 to 2% intensity: an 8.5% premium to the company’s tax rate
    • greater than 2% intensity: a 16.5% premium to the company’s tax rate.
  • The expenditure threshold has increased from $100 million to $150 million. For notional deductions above $150 million, the R&D tax offset rate is the corporate tax rate. The R&D premium does not apply.
  • The feedstock, clawback and adjustment provisions have been replaced with an exact amount rather than an approximation.
  • The general anti-avoidance provisions of Part IVA of the Income Tax Assessment Act 1936 includes an R&D tax offset as a tax benefit from 1 July 2021.
  • The ATO is required to publish a company’s claimed R&D expenditure. The first publication is to be made 2 years after the end of the financial year, and as soon as practicable after 1 July 2024.

Anti-avoidance rules #

The general anti-avoidance rule of Part IVA of the Income Tax Assessment Act 1936 now includes R&D tax offsets as a tax benefit for Part IVA from 1 July 2021.

A tax benefit arising out of on R&D claim may be summarised as:

  • The R&D entity entered into a scheme to access the R&D tax offset.
  • A tax benefit is received in connection with the scheme.
  • The dominant purpose of the R&D entity entering into the scheme is to either:
    • enable it to get the R&D tax offset
    • get a refundable R&D tax offset where it would have or reasonably be expected to have obtained a non-refundable R&D tax offset.

If Part IVA applies to an arrangement, the tax benefits obtained from the arrangement can be cancelled.

Publishing a company’s R&D expenditure #

We are required to publish R&D expenditure claimed by an R&D entity 2 years after the end of the financial year. The first publication will be as soon as practicable after 1 July 2024 for the income year ending 30 June 2022.

Publishing this information will improve public accountability for R&D claimants and encourage voluntary compliance with the R&D program.

The information we publish from the forms lodged with us includes:

  • the name of the R&D entity
  • Australian business number (ABN) or Australian company number (ACN)
  • notional deductions claimed (less any feedstock adjustments).

Custom Accounting Solutions

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.